Literature DB >> 12387745

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.

Emmanuel Dejardin1, Nathalie M Droin, Mireille Delhase, Elvira Haas, Yixue Cao, Constantin Makris, Zhi-Wei Li, Michael Karin, Carl F Ware, Douglas R Green.   

Abstract

The lymphotoxin-beta receptor (LTbetaR) plays critical roles in inflammation and lymphoid organogenesis through activation of NF-kappaB. In addition to activation of the classical NF-kappaB, ligation of this receptor induces the processing of the cytosolic NF-kappaB2/p100 precursor to yield the mature p52 subunit, followed by translocation of p52 to the nucleus. This activation of NF-kappaB2 requires NIK and IKKalpha, while NEMO/IKKgamma is dispensable for p100 processing. IKKbeta-dependent activation of canonical NF-kappaB is required for the expression but not processing of p100 and for the expression of proinflammatory molecules including VCAM-1, MIP-1beta, and MIP-2 in response to LTbetaR ligation. In contrast, IKKalpha controls the induction by LTbetaR ligation of chemokines and cytokines involved in lymphoid organogenesis, including SLC, BLC, ELC, SDF1, and BAFF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387745     DOI: 10.1016/s1074-7613(02)00423-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  341 in total

1.  Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.

Authors:  Lisa A Madge; Michael J May
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  The role of nuclear factor κB in the interferon response.

Authors:  Lawrence M Pfeffer
Journal:  J Interferon Cytokine Res       Date:  2011-06-01       Impact factor: 2.607

3.  Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen.

Authors:  Miho Sato-Hashimoto; Yasuyuki Saito; Hiroshi Ohnishi; Hiroko Iwamura; Yoshitake Kanazawa; Tetsuya Kaneko; Shinya Kusakari; Takenori Kotani; Munemasa Mori; Yoji Murata; Hideki Okazawa; Carl F Ware; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

4.  Finding NEMO: genetic disorders of NF-[kappa]B activation.

Authors:  Jordan S Orange; Raif S Geha
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

5.  A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.

Authors:  Jennifer L Gommerman; Keith Giza; Stuart Perper; Irene Sizing; Apinya Ngam-Ek; Cheryl Nickerson-Nutter; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 6.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

7.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

8.  Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.

Authors:  Wei Wang; Nicholas F Parchim; Takayuki Iriyama; Renna Luo; Cheng Zhao; Chen Liu; Roxanna A Irani; Weiru Zhang; Chen Ning; Yujin Zhang; Sean C Blackwell; Lieping Chen; Lijian Tao; M John Hicks; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

9.  TRAF3 enforces the requirement for T cell cross-talk in thymic medullary epithelial development.

Authors:  S Rhiannon Jenkinson; Joy A Williams; Hyein Jeon; Jingjing Zhang; Takeshi Nitta; Izumi Ohigashi; Michael Kruhlak; Saulius Zuklys; Susan Sharrow; Anthony Adams; Larry Granger; Yongwon Choi; Ulrich Siebenlist; Gail A Bishop; Georg A Hollander; Yousuke Takahama; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

10.  Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation.

Authors:  Nagalakshmi Nadiminty; Wei Lou; Soo Ok Lee; Xin Lin; Donald L Trump; Allen C Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.